-
1
-
-
0034998436
-
Oxcarbazepine, an antiepileptic agent
-
Kalis MM, Huff NA: Oxcarbazepine, an antiepileptic agent. Clinical Therapeutics 23:680-700, 2001.
-
(2001)
Clinical Therapeutics
, vol.23
, pp. 680-700
-
-
Kalis, M.M.1
Huff, N.A.2
-
2
-
-
0036929584
-
Safety profile of atomoxetine in the treatment of children and adolescents with ADHD
-
Wernicke JF, Kratochvil CJ: Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. Journal Clinical Psychiatry 63 Suppl 12:50-55, 2002.
-
(2002)
Journal Clinical Psychiatry
, vol.63
, Issue.SUPPL. 12
, pp. 50-55
-
-
Wernicke, J.F.1
Kratochvil, C.J.2
-
3
-
-
0035571150
-
Clinical pharmacology and therapeutic use of the new antiepileptic drugs
-
Perucca E: Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundamental Clinical Pharmacology 15:405-417, 2001.
-
(2001)
Fundamental Clinical Pharmacology
, vol.15
, pp. 405-417
-
-
Perucca, E.1
-
4
-
-
2442492624
-
Bradycardia, hypotension, and tinnitus after accidental oxcarbazepine overdose
-
Jolliff BJ, Fehrenbacher N, Dart RC: Bradycardia, hypotension, and tinnitus after accidental oxcarbazepine overdose. Clinical Toxicology 39:316-317, 2001.
-
(2001)
Clinical Toxicology
, vol.39
, pp. 316-317
-
-
Jolliff, B.J.1
Fehrenbacher, N.2
Dart, R.C.3
-
6
-
-
0036644683
-
Comparison of the subjective, physiological and psychomotor effects of atomoxetine and methylphenidate in light drug users
-
Heil SH, Holmes HW, Bickel WK et al: Comparison of the subjective, physiological and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Dependence 67:149-156, 2002.
-
(2002)
Drug Alcohol Dependence
, vol.67
, pp. 149-156
-
-
Heil, S.H.1
Holmes, H.W.2
Bickel, W.K.3
-
8
-
-
0034990035
-
Asymptomatic QTc prolongation associated with quetiapine overdose in a patient being treated with risperidone
-
Beelen AP, Yeo KT, Lewis LD: Asymptomatic QTc prolongation associated with quetiapine overdose in a patient being treated with risperidone. Hum Exp Toxicol. 20:215-219, 2001.
-
(2001)
Hum Exp Toxicol
, vol.20
, pp. 215-219
-
-
Beelen, A.P.1
Yeo, K.T.2
Lewis, L.D.3
-
12
-
-
0021915377
-
Single-dose and steady-state pharmacokinetics of atomoxetine in normal subjects
-
Farid NA, Bergstrom RF, Ziege EA et al: Single-dose and steady-state pharmacokinetics of atomoxetine in normal subjects. J Clin Pharmacol 25:296-301, 1985.
-
(1985)
J Clin Pharmacol
, vol.25
, pp. 296-301
-
-
Farid, N.A.1
Bergstrom, R.F.2
Ziege, E.A.3
-
13
-
-
0031784748
-
Quetiapine, an atypical antipsychotic
-
Goren JL, Levin GM: Quetiapine, an atypical antipsychotic. Pharmacotherapy 18:1183-1194, 1998.
-
(1998)
Pharmacotherapy
, vol.18
, pp. 1183-1194
-
-
Goren, J.L.1
Levin, G.M.2
-
14
-
-
2442612473
-
-
Novartis Pharmaceuticals Corp, East Hanover, NJ (PI revised 5/2001), reviewed 6/2002
-
Product Information: Trileptal(R), oxcarbazepine. Novartis Pharmaceuticals Corp, East Hanover, NJ (PI revised 5/2001), reviewed 6/ 2002.
-
Trileptal(R), Oxcarbazepine
-
-
-
15
-
-
0028991494
-
ICI 204,636, a novel, atypical antipsychotic: Early indication of safety and efficacy in patients with chronic and subchronic schizophrenia
-
Fabre LF Jr, Arvanitis L, Pultz J et al: ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia. Clin Therap 17:366-378, 1995.
-
(1995)
Clin Therap
, vol.17
, pp. 366-378
-
-
Fabre Jr., L.F.1
Arvanitis, L.2
Pultz, J.3
|